CLINICAL RESEARCH CURRICULUM AND MENTORSHIP PROGRAM

德克萨斯大学休斯顿医学院和公共卫生学院与德克萨斯大学医学博士安德森癌症中心提出了一个联合计划，以培养成功的临床研究人员。 该计划具有以下优势： 1. 隶属于同一大学系统的3个主要机构之间的密切合作，位于美国最大的医疗中心-一所年轻的医学院，获得的补助金不断增加，一所强大的公共卫生学院（在NIH总奖项中排名第三），以及一所大型癌症中心（在NCI总奖项中排名第二）。 2. 高度承诺，完成，和多样化的教师和咨询委员会PI是一个肿瘤学家和流行病学家和医学和公共卫生的UT休斯顿的米歇尔贝恩杰出教授;共同PI是一个著名的肿瘤学家和露丝哈里特安斯沃思教授的发展治疗学，医学教授，医学博士安德森实验室医学和病理学教授。咨询委员会包括公共卫生学院院长; MD安德森的教育项目和研究管理副总裁以及医学和外科负责人;以及医学院内科，儿科，产科和综合生物学（1998年诺贝尔医学奖赢家）的主席。 3. 一个实用和创新的计划，包括1）由来自所有3个机构的成功教师教授的综合课程，2）一个密集的导师计划，参与者每个人都与一个计划导师和一个临床导师一起工作，以准备一个值得资助的研究提案。成功完成该计划的参与者将获得认证，并为公共卫生学院的进一步课程提供学费。 4. 庞大的患者群体和临床研究资源基础。去年，UT休斯顿有超过100万门诊人次，233，000住院人次和1.08亿美元的研究支出; MD安德森招收了近20，000名新癌症患者，研究支出超过1.2亿美元。 5. 相当多的参与者。 我们预计每年在导师计划中保持>25名参与者，每节课程的平均参与者> 80名。 该计划很可能是成本效益的发展生产性临床研究者“谁是竞争力，寻求研究支持和知识的复杂问题与...健全的临床研究。"

The University of Texas-Houston Medical School and School of Public Health in conjunction with the University of Texas M.D. Anderson Cancer Center propose a joint program to develop successful clinical investigators. This program has the following strengths: 1. Close collaboration between 3 major institutions affiliated with the same university system and located in the largest medical center in the U.S.--a young medical school with progressively increasing grant awards, a strong school of public health (3rd among such schools in total NIH awards), and a large cancer center (2nd in total NCI awards). 2. Highly committed, accomplished, and diverse faculty and Advisory Board The PI is a neonatologist and epidemiologist and the Michelle Bain Distinguished Professor of Medicine and Public Health at UT Houston; the Co-PI is an eminent oncologist and the Ruth Harriet Ainsworth Professor of Developmental Therapeutics, Professor of Medicine, and Professor of Laboratory Medicine and Pathology at MD Anderson. The Advisory Board includes the Dean of the School of Public Health; the Vice Presidents of Educational Programs and of Research Administration and the Heads of Medicine and Surgery at MD Anderson; and the Chairmen of Internal Medicine, Pediatrics, Obstetrics, and Integrative Biology (1998 Nobel Prize Winner in Medicine) at the Medical School. 3. A practical and innovative program that includes 1) a comprehensive curriculum taught by successful faculty from all 3 institutions and 2) an intensive mentorship program in which participants each work with a program mentor and a clinical mentor to prepare a research proposal worthy of funding. Participants who successfully complete the program will be certified and provided tuition for further courses at the School of Public Health. 4. A large patient population and resource base for clinical research. Last year, UT Houston had more than 1 million outpatient visits, 233,000 hospital admissions and $108 million in research expenditures; MD Anderson enrolled almost 20,000 new cancer patients and had more than $120 million in research expenditures. 5. A sizable number of participants. We anticipate maintaining >25 participants in the mentorship program each year and a mean of >_80 participants at each session of the curriculum. This program is likely to be cost-effective in developing productive clinical investigators "who are competitive in seeking research support and knowledgeable about the complex issues associated with ... sound clinical research."